Position in BLLN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,937,350
New position
Shares Held
24,482
first reported quarter
Ownership
0.052%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#63
of 156 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026OpenArc Corporate Advisory, LLC holds $22,415,267 across 8 Diagnostics & Research names. BLLN ranks #3 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
21,861 | $10,960,230 | |
| 2 | NTRA |
Natera, Inc.
|
19,490 | $5,290,560 | |
| 3 | BLLN |
BillionToOne, Inc.
This page
|
24,482 | $2,937,350 | |
| 4 | DHR |
Danaher Corp /De/
|
6,615 | $1,260,025 | |
| 5 | A |
Agilent Technologies, Inc.
|
7,613 | $1,011,234 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
1,730 | $334,270 | |
| 7 | DGX |
Quest Diagnostics Inc
|
1,517 | $321,528 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
570 | $300,070 |
All Filings in BLLN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,937,350 | 24,482 | Shares | Sole | 2026-08-05 | |
| No filing history on record for this holder in this stock. | ||||||